https://wiki.tiffa.net/w/index.php?action=history&feed=atom&title=Translations%3ADiscovery_and_development_of_angiotensin_receptor_blockers%2F39%2Fen 2026-05-20T19:03:22Z Revision history for this page on the wiki MediaWiki 1.43.0 https://wiki.tiffa.net/w/index.php?title=Translations:Discovery_and_development_of_angiotensin_receptor_blockers/39/en&diff=131496&oldid=prev 2024-03-28T01:25:31Z

<p>Importing a new version from external source</p> <p><b>New page</b></p><div>==Drug comparison and pharmacokinetics==<br /> {| class=&quot;wikitable&quot; border=&quot;1&quot;<br /> |+ Table 1: Comparison of ARB [[pharmacokinetics]]<br /> |-<br /> ! Drug<br /> ! Biological half-life [h]<br /> ! Protein binding [%]<br /> ! Bioavailability [%]<br /> ! Renal/hepatic [[Clearance (medicine)|clearance]] [%]<br /> ! Food effect<br /> ! Daily dosage [mg]<br /> |-<br /> | [[Losartan]]<br /> | 2<br /> | 98.7<br /> | 33<br /> | 10/90<br /> | Minimal<br /> | 50-100<br /> |-<br /> | [[EXP 3174]]<br /> | 6-9<br /> | 99.8<br /> | -<br /> | 50/50<br /> | -<br /> | -<br /> |-<br /> | [[Candesartan]]<br /> | 9<br /> | &gt;99<br /> | 15<br /> | 60/40<br /> | No<br /> | 4-32<br /> |-<br /> | [[Valsartan]]<br /> | 6<br /> | 95<br /> | 25<br /> | 30/70<br /> | 40-50% decreased by<br /> | 80-320<br /> |-<br /> | [[Irbesartan]]<br /> | 11-15<br /> | 90-95<br /> | 70<br /> | 1/99<br /> | No<br /> | 150-300<br /> |-<br /> | [[Telmisartan]]<br /> | 24<br /> | &gt;99<br /> | 42-58<br /> | 1/99<br /> | No<br /> | 40-80<br /> |-<br /> | [[Eprosartan]]<br /> | 5<br /> | 98<br /> | 13<br /> | 30/70<br /> | No<br /> | 400-800<br /> |-<br /> | [[Olmesartan]]<br /> | 14-16<br /> | &gt;99<br /> | 29<br /> | 40/60<br /> | No<br /> | 10-40<br /> |-<br /> | colspan=&quot;7&quot; style=&quot;text-align: center;&quot; |Sources:<br /> |}</div>

FuzzyBot